NYSE:ABTMedical Equipment
Assessing Abbott (ABT) Valuation After New Lingo CGM Expansion and Protein-Glucose Data Release
Abbott Laboratories (ABT) just widened the audience for its Lingo glucose sensor by rolling it out on Android, pairing that step with fresh real world data on how protein intake shapes daily glucose control.
See our latest analysis for Abbott Laboratories.
Those Lingo updates and new Ensure protein launches land while Abbott’s 1 year total shareholder return of about 10 percent edges ahead of its year to date share price return near 9 percent, suggesting steady long term momentum despite...